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taneous involvement, the number of affected tracts,
and the presence of anti-Scl-70 antibodies. 
Keywords: Microcirculation; Nailfold capillaros-
copy; Raynaud’s phenomenon; Systemic sclerosis.
Resumo
Objectivo:Correlacionar parâmetros quantitativos
e semiquantitativos da capilaroscopia perinun-
gueal (CPU) com a extensão do acometimento cu-
tâneo, envolvimento visceral e alterações sorológi-
cas em pacientes com esclerose sistêmica (ES).
Métodos: A presença de alterações clínicas e soro-
lógicas foi avaliada retrospectivamente e correlacio-
nada com os achados capilaroscópicos (número de
capilares/mm, score de deleção vascular e número
de capilares ectasiados e megacapilares). Para ava-
liação da extensão da doença, cinco manifestações
foram analisadas: lesões em polpa digital, acometi-
mento cutâneo, envolvimento esofagiano, doença
pulmonar intersticial e hipertensão pulmonar.
Resultados: Foram avaliadas 105 CPUs realizadas
em 92 pacientes, 13 dos quais foram avaliados em
dois tempos diferentes. Pacientes com ES forma
cutânea difusa apresentaram maior score de dele-
ção vascular do que pacientes com ES forma cutâ-
nea limitada, ES sine scleroderma SSc e em super-
posição (1,67±0,91 vs 0,99±0,82; p=0,0005). O score
cutâneo de Rodnan modificado se correlacionou
positivamente com desvascularização capilar, ava-
liado pelo score de deleção vascular e pelo número
de capilares/mm (p<0,001, p=0,012; respectiva-
mente). Pacientes com três ou mais órgãos acome-
tidos apresentaram menor número de capila-
res/mm (8,00±1,69 vs 9,23±1,31 capilares/mm;
p=0,025) e maior score de deleção vascular
(1,41±0,95 vs 0,73±0,76; p=0,027) em comparação
com pacientes com menos de três órgãos acome-
tidos. O score de deleção vascular foi significativa-
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Abstract
Objective: The aim of this study was to correlate
quantitative and semiquantitative nailfold capilla-
roscopy (NFC) parameters with the extent of cuta-
neous and visceral involvement in systemic sclero-
sis (SSc) patients. 
Methods: The presence of clinical and serological
alterations was evaluated retrospectively and cor-
related with NFC findings (number of capillary
loops/mm, vascular deletion score and number of
enlarged and giant capillary loops). For evaluation
of disease extension five manifestations were ana-
lyzed: finger pad lesions, skin involvement, esop-
hageal involvement, interstitial lung disease, and
pulmonary hypertension.
Results: There were 105 NFC examinations in 
92 patients, 13 of whom were evaluated at two 
different time points. Patients with diffuse cutane-
ous SSc had a higher vascular deletion score than
patients with limited cutaneous SSc, sine sclero-
derma SSc, and overlap syndrome (1.67±0.91 
vs 0.99±0.82; p=0.0005). Modified Rodnan’s skin
score correlated positively with capillary deletion,
evaluated by the vascular deletion score and the
number of capillary loops/mm (p<0.001 and
p=0.012; respectively). Patients with three or more
involved tracts presented lower number of capillary
loops/mm (8.00±1.69 vs 9.23±1.31 capillary 
loops/mm; p=0.025) and a higher vascular deletion
score (1.41±0.95 vs 0.73±0.76; p=0.027) when 
compared to patients with less than three affected
tracts. Vascular deletion score was significantly 
higher in patients with anti-Scl-70 antibodies 
that in patients without anti-Scl-70 antibodies
(p=0.02). 
Conclusions: NFC abnormalities correlated posi-
tively with the diffuse form of SSc, the degree of cu-
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mente maior nos pacientes com anticorpos anti-
Scl-70 quando comparados com pacientes com au-
sência destes anticorpos (p=0,02).
Conclusões:Alterações na CPU se correlacionaram
positivamente com a forma cutânea difusa da ES,
o grau de acometimento cutâneo, o número de ór-
gãos envolvidos e a presença de anticorpos anti-
Scl-70.
Palavras-Chave: Microcirculação; Capilaroscopia
Periungueal; Fenômeno de Raynaud; Esclerose Sis-
têmica.
Introduction
Systemic Sclerosis (SSc) is an autoimmune rheu-
matic disease of unknown etiology characterized by
vascular alterations and tissue fibrosis of multiple
organs. It affects mostly the skin, musculoskeletal
system, heart, kidneys, lungs and gastrointestinal
tract.1 Vascular structural alterations and lesions
are detected early and seem to play an important
role in SSc pathogenesis. Dysfunction of vascular
tone control, endothelial activation/lesion, and
myointimal cell proliferation of small blood ves-
sels and capillaries result in progressive reduction
of vessel lumen, decreased blood flow, and a state
of chronic hypoxia.2,3 In the periphery, microvascu-
lar damage is characterized by enlargement and
distortion of capillary loops, micro-haemorrhages
and progressive devascularization.4,5
Peripheral microangiopathy can be easily recog-
nized by widefield nailfold capillaroscopy (NFC), a
noninvasive and safe method, that is well establi-
shed in the investigation of patients with Raynaud’s
phenomenon and SSc.5,6 Patients with SSc exhibit a
typical pattern at NFC, designated “SD pattern” by
Maricq et al., and characterized by enlargement of
capillary loops, loss of capillaries, disruption of the
orderly appearance of the capillary bed and distor-
tion of capillaries.7 Maricq et al., defined also two
major nailfold capillary patterns, namely  the “ac-
tive” (extensive loss of capillaries and minimal ca-
pillary enlargement) and the “slow” (capillary en-
largement and/or extremely enlarged capillaries
with no or minimal capillary loss) pattern.5 Re-
cently, Cutolo et al., have reclassified the scleroder-
ma microangiopathy into 3 different patterns: “ear-
ly”, “active” and “late” pattern.8 The early pattern is
characterized by few enlarged/giant capillaries, few
hemorrhages, relatively well-preserved capillary
distribution and no evident loss of capillaries; in
the “active” pattern there are frequent giant capil-
laries and hemorrhages, moderate loss of capilla-
ries, mild disorganization of the capillary architec-
ture, absence or mild ramified capillaries, and pre-
sence of edema; the “late” pattern is characterized
by irregular enlargement of the capillaries, few or
no giant capillaries and hemorrhages, severe loss
of capillaries with extensive avascular areas, disor-
ganization of the normal capillary array, and pre-
sence of ramified/bushy capillaries.8 The SD pat-
tern has been observed in 84-97% of SSc patients
but is not strictly limited to patients with SSc and
can also be found in dermatomyositis, mixed con-
nective tissue disease, and overlap syndromes with
SSc.4,5,9,10 Several studies have addressed a possible
relationship between NFC alterations and the ex-
tent of skin and visceral involvement in SSc.11-15 The
apparently controversial findings of some of these
studies are possibly due to small and heterogene-
ous samples of patients and also to heterogeneous
methodology in the interpretation of NFC findings.
Our group has previously reported on a repro-
ducible NFC method, comprehending several mi-
croangiopathic parameters assessed in quantitati-
ve and semiquantitative manner, evaluating all 10
fingers of the hands.6 The aim of the present study
was to report the morphological alterations in the
peripheral microcirculation, evaluated by panora-
mic nailfold capillaroscopy (NFC) using the me-
thod proposed by Andrade et al.,6 and to correlate
these microvascular abnormalities with cutaneous
and visceral involvement, in a large sample of pa-
tients with SSc. 
Patients and Methods
Patients
This was a retrospective study which included all
SSc patients seen in a two-year interval (2003-2004)
at the Scleroderma Spectrum Outpatient Clinic at
Federal University of São Paulo (UNIFESP) Medi-
cal School Hospital. All patients with at least one
NFC exam performed in the last 15 years were in-
cluded in the study. SSc diagnosis was based on the
American College of Rheumatology (ACR) crite-
ria.16 Disease subtype was classified as follows: dif-
fuse cutaneous SSc (skin thickening on the trunk,
face, in addition to proximal and distal extremi-
ties), limited cutaneous SSc (skin thickening loca-
lized to the face and neck, and distal to the elbows
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and knees), sine scleroderma SSc, and in overlap
syndromes.17,18 For further clinical, serological and
capillaroscopic analysis patients were divided into
two groups: diffuse SSc and non-diffuse SSc. The
latter category comprised patients with limited cu-
taneous SSc, sine scleroderma SSc and patients
with overlap syndromes. 
Nailfold capillaroscopy 
All NFCs were performed in a stereomicroscope
(Olympus - SZ40) under 10-20 x magnification
according to the protocol proposed by Andrade et
al.6 All the ten digits of the hands were examined,
except when prevented by extremely poor visibi-
lity or amputation. The following parameters were
analyzed: (1) number of capillary loops/mm, (2)
vascular deletion score, (3) number of enlarged
loops (about four times the normal afferent, tran-
sition, and efferent limbs width), and (4) number
of giant capillary loops (10 or more times the nor-
mal width of capillary limbs). Enlarged and giant
loops were counted together. The vascular dele-
tion score was assessed according to Lee’s me-
thod,19 in which a deletion area is defined as the ab-
sence of two or more consecutive loops. Each fin-
ger was rated from 0 to 3: grade 0 – no deletion
area; 1 – one or two discrete deletion areas; 2 –
more than two discrete deletion areas; 3 – extensi-
ve and confluent deletion areas. For each patient
the NFC parameters were calculated as the avera-
ge obtained in all analyzed digits. 
During the 15-year period NFCs were perfor-
med by three investigators with similar NFC trai-
ning. All exams were performed according to the
same NFC protocol, and examiners had no infor-
mation about the patient’s clinical condition. Re-
producibility of the NFC examination was tested as
previously described.6
Clinical and laboratory evaluation
All clinical and laboratory data were collected re-
trospectively from medical charts according to a
standardized protocol routinely filled out at each
visit to the Scleroderma Spectrum Outpatient Cli-
nic during the period of 1989 to 2004. 
The presence and extent of cutaneous involve-
ment was assessed by the modified Rodnan’s skin
score.20 Finger pad lesions were defined as the pre-
sence of active digital ulcerations, digital pitting
scars, resorption and/or digital amputations. Eso-
phageal involvement was evaluated by the presen-
ce of esophageal dismotility on barium contrast
roentgenographic study of the upper gastrointes-
tinal tract. The presence of lung interstitial disea-
se was defined by forced vital capacity (FVC) < 75%
of the predicted values and/or bibasal interstitial
pulmonary infiltrate on chest radiogram and/or
high resolution computed tomography (HRCT)
showing ground-glass opacities, reticular or ho-
neycombing pattern. Pulmonary hypertension
was defined by pulmonary systolic arterial pressu-
re (PSAP) >35mmHg, estimated on Doppler echo-
cardiography. Finally, renal scleroderma crisis was
defined by the presence of malignant hyperten-
sion and renal failure.
For evaluation of disease extension five manifes-
tations were analyzed: (1) finger pad lesions, (2)
presence of skin thickness, (3) presence of esopha-
geal dismotility on barium study, (4) interstitial
lung disease, and (5) presence of pulmonary hyper-
tension. Only patients with available information
on these five manifestations were included. 
Antinuclear antibodies (ANA) were determined
by indirect immunofluorescence using HEp-2 cell
as substrate. Anticentromere antibodies were iden-
tified by the typical pattern on the indirect immu-
nofluorescence HEp-2 cell assay and anti-topoi-
somerase I (anti-Scl-70) antibodies were determi-
ned by the double immunodiffusion method
against rabbit thymus extract.
For all included patients, the clinical-laboratory
evaluation was not more than 12 months apart the
NFC evaluation. Patients with more than one NFC
made more than 12 months apart were handled in
two alternative ways. If the NFCs conclusions were
different (normal NFC or nonspecific capillary al-
terations on the first exam and presence of SD pat-
tern on the second, or the contrary), the clinical
and laboratorial findings were analyzed at each
time and compared to the relevant NFC exam. Al-
ternatively, if the NFCs conclusions were similar in
both occasions, only the NFC with closest availa-
ble clinical-laboratory evaluation was taken into
consideration. However, if the interval between
NFCs was higher than three years each NFC/clini-
cal/laboratory set was individually analyzed. Pati-
ents with no NFC record were excluded from the
study.
Statistical analysis
Results are presented as mean and standard devia-
tion. Correlations between NFC, clinical and labo-
ratory parameters were evaluated by Pearson’s or
Spearman’s correlation analysis. Associations
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between qualitative parameters were analyzed by
the Chi square test. Mann-Whitney’s test was used
to compare quantitative variables. p <0.05 was con-
sidered significant.
Results
One hundred and five NFCs were evaluated in 92
patients, 13 of whom were evaluated at two diffe-
rent moments within a time interval varying from
2.5 to 12 years. The mean age of patients (79 wo-
men and 13 men) at each NFC evaluation was 47.4
years (ranging from 19 to 71) and the mean age at
disease onset was 40.1 ± 13.9 years (ranging from
11 to 68). Thirty-two patients (35%) had diffuse cu-
taneous SSc and 60 (65%) had non-diffuse SSc,
comprising 42 (45.65%) with limited cutaneous
SSc, 8 (8.7%) with SSc sine scleroderma, and 10
(10.9%) with SSc in the context of overlap syndro-
me (one with rheumatoid arthritis, five with
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polymyositis and four with systemic lupus erythe-
matosus) and with cutaneous involvement limi-
ted to the face and distal extremities. Among the
105 evaluations, 35 were in patients with diffuse cu-
taneous SSc, and 70 in patients with non-diffuse
SSc. The clinical and laboratory characteristics of
the patients in each evaluation are depicted in Ta-
ble I. The duration of RP at time of the NFC evalua-
tion was significantly longer in patients with non-
diffuse SSc as compared with those with diffuse
cutaneous disease (p=0.008). The mean modified
Rodnan’s skin score was 20.86 ± 11.64 in patients
with diffuse SSc and 6.81 ± 6.45 in patients with
non-diffuse SSc. 
SD pattern was found in 84% of the NFCs. The
mean number of capillary loops/mm was 8.06 ±
1.72. The mean number of enlarged and giant ca-
pillary loops in each digit was 3.38 ± 2.92 capilla-
ries, and the mean vascular deletion score was 1.22
± 0.91. 
Patients with diffuse cutaneous SSc showed hi-
Table I. Clinical and laboratory characteristics of Systemic Sclerosis (SSc) patients
Diffuse Non-diffuse Total of P (Diffuse vs
Clinical and laboratorial cutaneous SSc SSc Evaluations Non-diffuse 
characteristics (n=35) (n=70) (n=105) SSc)
Disease duration (years) 5.29 ± 4.10 8.61 ± 7.78 7.37 ± 6.92 P= 0.03
Vascular
Raynaud's phenomenon (RP) 34/35 (97%) 66/69 (96%) 100/104 (96%) NS
Duration of RP (years) 4.29 ± 3.40 8.40 ± 8.13 7.06 ± 7.24 P= 0.008
Alterations of  digital pad 26/31 (84%) 29/45 (64%) 55/76 (72%) NS
Skin thickness 33/34 (97%) 58/69 (84%) 91/103 (88%) NS
Telangiectases 9/24 (37.5%) 28/41 (68%) 37/65 (57%) P= 0.016
Calcinoses 2/21 (9.5%) 2/22 (9%) 4/43 (9%) NS
Esophageal involvement
Disfagia 18/34 (53%) 37/65 (57%) 55/99 (55%) NS
Esophageal hypomotility 15/26 (58%) 33/50 (66%) 48/76 (63%) NS
Interstitial lung disease
FVC < 75% 16/29 (55%) 22/64 (34%) 38/93 (40%) NS
Bibasal interstitial pulmonary
infiltrate on chest radiogram 8/15 (53%) 17/37 (46%) 25/52 (48%) NS
HRCT with ground-glass opacities, 15/20 (75%) 21/27 (78%) 36/47 (77%) NS
reticular patters or honeycombing
Pulmonary hypertension 3/29 (10%) 7/52 (13%) 10/81 (12%) NS
Renal scleroderma crisis 0/10 (0%) 0/32 (0%) 0/42 (0%) NS
Antinuclear antibodies 28/34 (82%) 62/69 (90%) 90/103 (87%) NS
Anticentromere 0/30 (0%) 22/62 (35%) 22/92 (24%) P<0.0001
Anti-Scl70 6/18 (33%) 4/22 (18%) 10/40 (25%) NS
FVC: forced vital capacity; HRCT: high resolution computed tomography; NS: not significant .
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gher vascular deletion scores than those with non-
diffuse disease (1.67±0.91 vs 0.99±0.82; p=0.0005).
In contrast, no statistically significant difference
was found between patients with diffuse cutaneous
SSc and those with non-diffuse disease concerning
the number of capillary loops/mm (7.75±1.80 vs
8.21±1.67 loops/mm; p=0.225) and the number of
enlarged and giant capillary loops (3.19±2.37 vs
3.46±3.17; p=0.852) (Figure 1). Modified Rodnan’s
skin score showed a moderate positive correlation
with vascular deletion score (r= 0.52; p<0.001) and
a modest negative correlation with the number of
capillary loops/mm (r = -0.26; p=0.012).
Patients with presence of finger pad lesions
showed higher vascular deletion scores and decrea-
sed number of capillary loops/mm than those with
absence of finger pad lesions (1.49 ± 0.90 vs 0.86 ±
0.82, p=0.01;  7.71 ± 1.79 vs 8.64 ± 1.15, p=0.03, res-
pectively) (Table II). Among patients with esopha-
geal dismotility, we found higher number of enlar-
ged and giant capillary loops than those with ab-
sence of esophageal dismotility (4.28 ± 3.27 vs 2.82
± 2.42, p=0.04). No difference was detected in the
three NFC parameters analyzed between patients
with pulmonary hypertension or interstitial lung
disease and patients without these manifestations
(Table II). 
Visceral involvement was studied in 50 patients
who had simultaneous records for the five manifes-
tations evaluated. These patients were classified
into those presenting up to two involved tracts
(n=10) and those presenting three or more involved
tracts (n=40). Patients with three or more involved
tracts showed lower number of capillary loops/mm
and higher vascular deletion score than patients
with less than three involved tracts (8.00±1.69 vs
9.23±1.31 loops/mm; p=0.025; and 1.41±0.95 vs
0.73±0.76; p=0.027, respectively) (Figure 2). There
was no difference in the number of enlarged and gi-
ant capillary loops between the two groups
(3.39±2.94 vs 3.24±2.34; p=0.98) (Figure 2).
The presence of anti-Scl-70 antibodies was stu-
died in 40 patients at the time of the NFC. The vas-
cular deletion score was significantly higher in pa-
tients with anti-Scl-70 antibodies (1.74±0.82) as
compared with patients without anti-Scl-70 antibo-
dies (1.11±0.96) (p=0.02). No significant difference
was found in the number of capillary loops/ /mm
or in the number of enlarged and giant capillary lo-
ops between patients with and without anti-Scl-70
antibodies (Table III). No patient with diffuse dise-
ase had anti-centromere antibody. Therefore, the
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Figure 1. Distribution of the number of capillary
loops/mm (a), number of enlarged and giant capillary 
loops (b) and, vascular deletion score (c) on nailfold 
capillaroscopy in patients with diffuse systemic sclerosis
(SSc) and non-diffuse SSc.
Box-Plot graph: Rectangles depict 50% of the sample; thick horizontal
bar corresponds to median; upper and lower horizontal bars 
represent highest and lowest figures.The symbol (*) represents 
outliers. N: number.
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association between anti-centromere antibodies
and NFC abnormalities was performed only for the
non-diffuse SSc patients. Among patients with
non-diffuse disease no significant difference in the
three NFC parameters was found between the 22
patients with anti-centromere antibodies and the
40 patients without anti-centromere antibodies
(Data not shown).
Discussion
The results herein obtained were derived from a
large sample of SSc patients retrospectively ana-
lyzed for NFC, clinical and laboratory variables. It
represents a retrospective analysis gathering the
cumulated 15-year experience using the same NFC
protocol in our center.6 This NFC protocol has the
advantage of gathering well-established quantita-
tive and semiquantitative parameters, such as the
number of capillary loops, the vascular deletion
score, and the number of enlarged loops analyzed
in all 10 fingers of the hands. The present results
showed a clear-cut association between the degree
of microangiopathic alterations detected by NFC
and the extent of cutaneous and visceral involve-
ment of the disease. Among the several nailfold
microvascular abnormalities observed in SSc the
parameters related to devascularization (vascular
deletion scores and/or number of capillary loops/
/mm), but not those related to capillary enlarge-
ment, were significantly associated with more ex-
tensive skin involvement, diffuse cutaneous SSc,
presence of finger pad lesions and with a more ex-
tensive visceral involvement. In addition, patients
with anti-Scl-70 antibodies had also higher vascu-
lar deletion scores. 
The microangiopathic abnormalities characte-
rized by devascularization and capillary enlarge-
ment are specifically observed in SSc and related
diseases and tend to occur at early stages of the di-
sease, what has granted a place for NFC in the cli-
nical investigation of SSc and in the differential di-
agnosis of Raynaud’s phenomenon.21,22 This is es-
pecially relevant for the evaluation of patients at
early stages of the disease, in which isolated Ray-
naud’s phenomenon may be the only clinical ma-
nifestation. In that way, NFC has been found to bee
especially helpful in distinguishing primary Ray-
naud’s phenomenon (functional, not related to di-
sease) from secondary Raynaud’s phenomenon.23
In a meta-analysis study, it has been found that
among patients with presumed primary Raynaud’s
phenomenon, a secondary disorder developed in
12% of patients.24 In patients with Raynaud’s phe-
nomenon NFC can be very helpful to exclude a se-
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Table II. Nailfold capillaroscopy (NFC) alterations and correlation with finger pad lesions, esophageal 
dismotility, pulmonary hypertension and interstitial lung disease 
Finger Pad Lesions
NFC alterations Present n Absent n P
N. of capillary loops/mm 7.71 ± 1.79 55 8.64 ± 1.15 21 0.03
N. of enlarged and giant capillary loops 3.89 ± 2.79 55 2.58 ± 2.18 21 NS
Vascular deletion score 1.49 ± 0.90 55 0.86 ± 0.82 21 0.01
Esophagel Dismotility
N. of capillary loops/mm 7.80 ± 1.44 48 8.51 ± 1.74 28 NS
N. of enlarged and giant capillary loops 4.28 ± 3.27 48 2.82 ± 2.42 28 0.04
Vascular deletion score 1.30 ± 0.86 48 1.04 ± 0.80 28 NS
Pulmonary Hypertension
N. of capillary loops/mm 8.93 ± 1.15 10 8.06 ± 1.69 71 NS
N. of enlarged and giant capillary loops 1.82 ± 1.91 10 3.68 ± 2.91 71 NS
Vascular deletion score 1.0 ± 0.82 10 1.31 ± 0.95 71 NS
Interstitial Lung Disease
N. of capillary loops/mm 8.18 ± 1.69 62 8.01 ± 1.62 38 NS
N. of enlarged and giant capillary loops 3.38 ± 2.99 62 3.97 ± 3.50 38 NS
Vascular deletion score 1.28 ± 0.95 62 1.12 ± 0.84 38 NS
N: number; NS: not significant.
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condary disorder, since it has a high negative pre-
dictive value for the development of a connective
tissue disease (>90%). On the other hand, its posi-
tive predictive value is about 50%, which is higher
than any other single screening test.23,24 The pos-
sibility that the NFC abnormalities might also cor-
relate with the extent of cutaneous and visceral in-
volvement in SSc is intriguing and could have im-
plications for the understanding of the disease pa-
thophysiology and for the clinical assessment of
patients. 
The results obtained in the present study con-
firm previous reports on a positive correlation
between the degree of abnormalities at NFC and
the extent of cutaneous and visceral involvement
in SSc.11,12,25-27 Maricq et al, in 1976, first studied this
issue by analyzing capillary abnormalities in 28
SSc patients, 13 with Raynaud’s phenomenon and
3 with dermatomyositis.11 A positive correlation
was found between the degree of microvascular
abnormalities and the number of affected systems.
In another study of the same group, a positive as-
sociation was founded between the presence of
the “active” pattern on NFC and more extensive
skin involvement. They also presented a higher fre-
quency of involvement of all organ systems than
those with a “slow” pattern.12 Recently, Ostojic and
Damjanov,25 also found more extensive capillary
loss in patients with diffuse cutaneous SSc compa-
ring to patients with limited SSc. Also in accordan-
ce with our findings, Bredemeier et al.,15 found a
positive correlation between the vascular deletion
score in NFC and higher Rodnan’s skin score, pre-
sence of anti-Scl-70 antibodies, signs of periphe-
ral ischemia, esophageal dysfunction and pulmo-
nary disease. On the other hand, some other stu-
dies could not find such association.14,28 Heteroge-
neity in patient selection and NFC methodology
may contribute to the lack of association observed
in the latter studies. 
In our study anti-Scl-70 antibodies were deter-
mined only in 40 patients at the time of the analy-
sis due to non-availability of anti-Scl-70 at the ins-
titution. Despite this limitation we found higher
vascular deletion scores in patients with anti-Scl-
-70 antibodies in the sera. The latter association
supports a possible relationship between disease
severity and NFC abnormalities since this autoan-
tibody has been previously demonstrated to be as-
sociated with more severe and extensive disease.29
The analysis of the present series of patients dis-
closed epidemiological features similar to those
LUCY T SATO E COL.
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Figure 2. Distribution of patients with up to two 
involvements or three or more involvements according
the number of capillary loops/mm (a), number of enlarged
and giant capillary loops (b) and, vascular deletion score
(c) on nailfold capillaroscopy.
Box-Plot graph: Rectangles depict 50% of the sample; thick horizontal
bar corresponds to median; upper and lower horizontal bars 
represent highest and lowest figures. N. number.
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registered in the literature in that there was fema-
le predominance, disease onset around 40 year old
in average, and the predominance of the cutane-
ous limited disease.17,30 As for the distribution of
clinical manifestation it is noteworthy that there
was no case of renal scleroderma crisis, what may
be due to bias of the retrospective study.
It is relevant to point out that the present study
represents a retrospective analysis of the cumula-
tive 15-year experience with NFC uniformly perfor-
med according to the protocol proposed by An-
drade et al.6 This protocol uses established quan-
titative and semi quantitative techniques, allowing
the concomitant determination of several parame-
ters that are strongly associated with SSc, such as
the number of capillary loops, the number of en-
larged loops and the degree of avascular score. It
should also be emphasized that conventional NFC
is a simple and low cost method, and therefore fea-
sible in any average Rheumatology Division. More
recently studies using videocapillaroscopy has
been also published with interesting results.26,31
However it should be noticed that this is a much
more expensive method and is restricted to specia-
list centers.
Nonetheless, the retrospective design of the
study bears some intrinsic limitations. For exam-
ple, not all patients followed in our hospital had the
necessary records for NFC, clinical and laboratory
data within a one-year interval and therefore could
not be included in the study. In addition only 50 pa-
tients could be included for the analysis of corre-
lation of NFC abnormalities and the number of in-
volved tracts, since the other ones did not have the
required simultaneous records for the five clinical
involvements. On the other hand, this particular
retrospective analysis is strengthened by the fact
that these patients have been followed by the same
standard protocol for clinical, laboratory and NFC
evaluation. 
Despite these limitations, the results obtained
showed a clear-cut association of the degree of
NFC microangiopathy with the extension of the
cutaneous and visceral involvement as well as with
the presence of anti-Scl-70 antibodies. Therefore,
it is appropriate to consider the NFC approach for
the evaluation of the extension and severity of SSc.
Prospective studies with long follow-up are war-
ranted to investigate a possible role for nailfold ca-
pillary microscopy in the prediction of disease ex-
tension and severity. 
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